Subscribe
Advertising
Contact Us
Medical News
Articles
TV & Video
Authors
About Medicine Magazine
Home
MEDICAL NEWS
Health
|
Biotechnology
|
Pharmaceutical
Pharmaceutical Headlines
Today is November 26, 2024. All times in Eastern Time.
Claudin 18.2 Targeted Therapy Market Forecast & Clinical Trials Insights Report 2024-2029: 60 Drugs Currently in Trials with 1 Approved (Vyloy: zolbetuximab) - ResearchAndMarkets.com
11/26/2024 - 01:11 PM
Nexus Pharmaceuticals Receives FDA Approval for Methylene Blue Injection, USP
11/26/2024 - 12:02 PM
Lung Cancer Therapy Research Report 2023-2024 & 2029: $70.39 Billion Market Analysis By Treatment Method, Therapy Type, Indication, End-User and Region - ResearchAndMarkets.com
11/26/2024 - 11:29 AM
Join Care Access for No-Cost Heart & Kidney Health Screenings in Palo Alto, Screening For Inherited Type of Heart Health Risk
11/26/2024 - 11:01 AM
Nutcracker Therapeutics Presents Precision Biomanufacturing and CRDMO Solutions at the 2024 Personalized Cancer Vaccine Summit
11/26/2024 - 09:56 AM
Vir Biotechnology to Host Virtual Investor Event on PRO-XTEN™ Masked T-Cell Engager Programs
11/26/2024 - 09:30 AM
S.BIOMEDICS Investigational Cell Therapy for Parkinson’s Disease With TED-A9 Shows Positive Data at 12-months in Phase 1/2a Clinical Trial
11/26/2024 - 09:00 AM
GE HealthCare unveils Pristina Via to streamline technologist workflow and improve patient-centered breast care
11/26/2024 - 09:00 AM
Immunology Biosimilars Market Research Report 2020-2024 & 2025-2030 with Analyst Recommendations - Focus on Complex Biosimilars, Leverage Digital Health - ResearchAndMarkets.com
11/26/2024 - 09:00 AM
Liquid Filled Capsule Market Analysis and Forecast, 2024-2034: Increased Focus on Nutraceuticals, Chronic Disease Management, Personalized Medicine and Sustainable Ingredients Fuels Momentum - ResearchAndMarkets.com
11/26/2024 - 08:49 AM
Swisslog Healthcare Appoints Yufei Chen as Global Innovation Executive
11/26/2024 - 08:47 AM
Lantern Pharma & Starlight Therapeutics Present LP-184 (STAR-001) Phase 1b Trial Design and Preclinical Data in Glioblastoma at Society for Neuro-Oncology (SNO) 2024 Highlighting Novel Synthetic Lethality
11/26/2024 - 08:45 AM
Cencora to Host Inaugural Product Showcase
11/26/2024 - 08:30 AM
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market
11/26/2024 - 08:07 AM
Care Access Makes Future of Medicine Program Available to Detroit with No-Cost Heart & Kidney Health Screenings
11/26/2024 - 08:05 AM
Care Access Launches Health Screening Initiative in Birmingham to Address Undetected Heart & Kidney Health Risks
11/26/2024 - 08:02 AM
Rallybio to Present at the 2024 Evercore ISI HealthCONx Conference
11/26/2024 - 08:00 AM
New Data from a Long-Term Follow-up Study to the OLYMPUS Trial Show Median Duration of Response of Four Years in Patients Who Achieved a Complete Response with JELMYTO®
11/26/2024 - 08:00 AM
Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference
11/26/2024 - 08:00 AM
Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference
11/26/2024 - 08:00 AM
AOM Infusion Is Now a Limited Distribution Partner of ALYGLO™ Immunoglobulin Replacement Therapy
11/26/2024 - 08:00 AM
Geistlich Announces Exclusive Distribution Partnership for its Leading Wound Care Portfolio in the United States
11/26/2024 - 07:30 AM
Sage Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
11/26/2024 - 07:00 AM
Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference
11/26/2024 - 07:00 AM
Sarepta Therapeutics Announces Global Licensing and Collaboration Agreement with Arrowhead Pharmaceuticals for Multiple Clinical and Preclinical siRNA Programs
11/26/2024 - 07:00 AM
1
2
3
4
5
6
7
8
9
10
Next »
Get Business Wire News on Your Website
Terms of Use
|
© 2024 Business Wire
Medical News
|
Articles
|
TV & Video
|
Authors
|
About Houston Medicine
|
Subscribe
|
Advertising
|
Masthead
|
Contact Us
Copyright 2004. World Publishing LLC. All rights reserved.
